首页> 外文期刊>Current computer-aided drug design >Computational Approaches as Rational Decision Support Systems for Discovering Next-Generation Antitubercular Agents: Mini-Review
【24h】

Computational Approaches as Rational Decision Support Systems for Discovering Next-Generation Antitubercular Agents: Mini-Review

机译:用于发现下一代抗细胞剂的合理决策支持系统的计算方法:迷你审查

获取原文
获取原文并翻译 | 示例
           

摘要

Tuberculosis, malaria, dengue, chikungunya, leishmaniasis etc. are a large group of neglectedtropical diseases that prevail in tropical and subtropical countries, affecting one billion peopleevery year. Minimal funding and grants for research on these scientific problems challengemany researchers to find a different way to reduce the extensive time and cost involved in the drugdiscovery cycle of these problems. Computer-aided drug design techniques have already beenproved successful in the discovery of new molecules rationally by reducing the time and cost involvedin the development of drugs. In the current minireview, we are highlighting on the molecularmodeling studies published during 2010-2018 for target specific antitubercular agents. This review includesthe studies of Structure-Based (SB) and Ligand-Based (LB) modeling and those involving MachineLearning (ML) techniques against different antitubercular targets such as dihydrofolatereductase (DHFR), enoyl Acyl Carrier Protein (ACP) reductase (InhA), catalase-peroxidase (KatG),enzyme antigen 85C, protein tyrosine phosphatases (PtpA and PtpB), dUTPase, thioredoxin reductase(MtTrxR), etc. The information presented in this review will help the researchers to get acquaintedwith the recent progress in the modeling studies of antitubercular agents.
机译:结核病,疟疾,登革热,Chikungunya,Leishmaniaisis等是热带和亚热带国家的一大群忽视疾病,影响了10亿人民的每年。最少的资金和拨款对这些科学问题的研究挑战,研究人员发现不同的方法来减少这些问题的繁体中悬浮循环中涉及的广泛时间和成本。通过减少药物发展的时间和成本,计算机辅助药物设计技术已经在发现新分子中发现了新的分子。在目前的Minireview中,我们突出显示2010 - 2018年用于靶特异性抗细胞剂的分子模型研究。该综述包括基于结构的(Sb)和基于配体的(LIGAND的(LB)建模的研究和涉及针对不同抗细胞靶(DHFR)(DHFR),ENOYL酰基载体蛋白(ACP)还原酶(INHA)的机械射靶(ML)技术的研究,过氧化氢酶 - 过氧化物酶(KATG),酶抗原85C,蛋白酪氨酸磷酸酶(PTPA和PTPB),DUTPASE,Thioredoxin还原酶(MTTRXR)等。本综述中提出的信息将有助于研究人员熟悉最近在建模研究中的进展情况抗节炎药剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号